VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $229 | +6.0% | 937 | 0.0% | 0.00% | – |
| Q2 2023 | $216 | – | 937 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | – | 937 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | – | 937 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 937 | -6.3% | 0.00% | – |
| Q4 2021 | $2,000 | -33.3% | 1,000 | -44.6% | 0.00% | – |
| Q3 2018 | $3,000 | +200.0% | 1,805 | +257.4% | 0.00% | – |
| Q2 2018 | $1,000 | -66.7% | 505 | -55.5% | 0.00% | – |
| Q1 2018 | $3,000 | -72.7% | 1,134 | -36.3% | 0.00% | -100.0% |
| Q3 2017 | $11,000 | +22.2% | 1,781 | -15.8% | 0.00% | 0.0% |
| Q2 2017 | $9,000 | +800.0% | 2,114 | +957.0% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 200 | -17.4% | 0.00% | – |
| Q1 2016 | $1,000 | -66.7% | 242 | -48.9% | 0.00% | – |
| Q2 2015 | $3,000 | -94.6% | 474 | -95.6% | 0.00% | -100.0% |
| Q1 2015 | $56,000 | +600.0% | 10,836 | +665.8% | 0.01% | +600.0% |
| Q4 2014 | $8,000 | – | 1,415 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Spectrum Planning & Advisory Services Inc. | 16,000 | $2,681 | 0.00% |
| Virtu Financial LLC | 37,424 | $6 | 0.00% |
| Affinity Capital Advisors, LLC | 22,265 | $3,729 | 0.00% |
| MORGAN STANLEY | 409,011 | $68,509 | 0.00% |
| HBK Sorce Advisory LLC | 20,575 | $3,447 | 0.00% |
| Bank of New York Mellon Corp | 39,000 | $6,533 | 0.00% |
| Harel Insurance Investments & Financial Services Ltd. | 11,000 | $2 | 0.00% |
| SIMPLEX TRADING, LLC | 100 | $0 | 0.00% |
| Tower Research Capital LLC (TRC) | 937 | $0 | 0.00% |
| ROYAL BANK OF CANADA | 798 | $0 | 0.00% |